BA
The Boeing Company
BA's fundamentals are strong: its operating margin went from โ10% to 10% and revenue grew 18%. Its PE isn't a useful guide right now because of how its recent earnings were reported.
XOS
Xos, Inc.
There isn't enough reported data to score XOS yet.
BA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Under pressure |
BA's profitability is currently healthy, and its revenue and cash flow are stable, but its balance sheet is under pressure.
XOS Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Weak | |
| Weak | |
| Unavailable |
XOS's revenue, profitability and cash flow are currently weak. There isn't enough data to rate its balance sheet.
BA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $172 | โ |
| Cheap | 51x | $496 | +189% |
| Fair | 82x | $790 | +360% |
| Expensive | 91x | $876 | +411% |
Historical ranges are pointers, not guarantees.
BA's PE is 18x, but its earnings don't support one, so it isn't a reliable read right now.
XOS PE Valuation
XOS has no meaningful PE right now: it lost money over the past year.
BA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect BA to return to profit, with revenue growing. However, they disagree widely on these estimates.
XOS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect XOS's losses to shrink, with revenue growing.
BA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $9.66 | +$23.38 |
| Q2 2026 | $2.78 | +$19.33 |
| Q1 2026 | $2.53 | +$20.49 |
| Q4 2025 | $2.48 | +$20.84 |
| Q3 2025 | -$13.72 | -$0.83 |
| Q2 2025 | -$16.55 | -$10.93 |
| Q1 2025 | -$17.96 | -$14.42 |
| Q4 2024 | -$18.36 | -$14.69 |
BA has the edge over XOS on earnings quality, reporting a profit while its opponent remains loss making.
XOS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.26 | +$2.03 |
| Q2 2026 | -$1.52 | +$4.31 |
| Q1 2026 | -$1.88 | +$4.27 |
| Q4 2025 | -$2.71 | +$3.98 |
| Q3 2025 | -$4.29 | +$2.37 |
| Q2 2025 | -$5.83 | +$1.91 |
| Q1 2025 | -$6.15 | +$4.56 |
| Q4 2024 | -$6.69 | +$6.42 |
XOS is still losing money, but far less than before: $2.26 per share over the past year, against $15.30 at its worst in mid-2023.
BA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.2B | +3.9% |
| Q2 2026 | $24.6B | +8% |
| Q1 2026 | $22.2B | +14% |
| Q4 2025 | $23.9B | +57% |
| Q3 2025 | $23.3B | +30% |
| Q2 2025 | $22.7B | +35% |
| Q1 2025 | $19.5B | +18% |
| Q4 2024 | $15.2B | -31% |
BA has the edge over XOS on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.5% | +22 points |
| Q2 2026 | 0.6% | +1.4 points |
| Q1 2026 | 2% | -0.3 points |
| Q4 2025 | 37% | +61 points |
| Q3 2025 | -21% | +12 points |
| Q2 2025 | -0.8% | +5.7 points |
| Q1 2025 | 2.4% | +2.9 points |
| Q4 2024 | -25% | -26 points |
BA has the edge over XOS on profitability, with a higher operating margin.
XOS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $5.5M | -66% |
| Q2 2026 | $4.7M | -74% |
| Q1 2026 | $11.2M | +91% |
| Q4 2025 | $5.2M | -55% |
| Q3 2025 | $16.5M | +4.5% |
| Q2 2025 | $18.4M | +18% |
| Q1 2025 | $5.9M | -55% |
| Q4 2024 | $11.5M | -38% |
XOS's revenue has slid since its 2025 peak: $6M last quarter, down 66% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -135% | -92 points |
| Q2 2026 | -168% | -129 points |
| Q1 2026 | -42% | +116 points |
| Q4 2025 | -187% | -60 points |
| Q3 2025 | -42% | +19 points |
| Q2 2025 | -39% | +35 points |
| Q1 2025 | -158% | -80 points |
| Q4 2024 | -127% | -63 points |
XOS's operating margin was โ135% last quarter, down 92 points from the same quarter a year ago.
BA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $464M | +95% |
| Q2 2026 | $631M | +$831M |
| Q1 2026 | -$1.5B | +$836M |
| Q4 2025 | $375M | +$4.5B |
| Q3 2025 | $238M | +$2.2B |
| Q2 2025 | -$200M | +$4.1B |
| Q1 2025 | -$2.3B | +$1.6B |
| Q4 2024 | -$4.1B | -239% |
BA has the edge over XOS on cash generation, producing positive trailing cash flow while its opponent burns cash.
XOS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$2.7M | -188% |
| Q2 2026 | -$2.7M | -158% |
| Q1 2026 | -$1.6M | +$3.1M |
| Q4 2025 | $2.4M | -27% |
| Q3 2025 | $3.1M | +$14.7M |
| Q2 2025 | $4.6M | +$30.8M |
| Q1 2025 | -$4.8M | +$9.9M |
| Q4 2024 | $3.3M | +$4.2M |
XOS has burned cash in most quarters: โ$5M over the past year, against $6M the year before.
BA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.0x | Elevated |
| Q2 2026 | 5.7x | High |
| Q1 2026 | 6.0x | High |
| Q4 2025 | 6.9x | High |
| Q2 2024 | 361.8x | High |
| Q1 2024 | 36.1x | High |
| Q4 2023 | 36.4x | High |
| Q3 2023 | 96.1x | High |
BA's net debt is about 3.0 years of its operating earnings (EBITDA), down from more than 20 years a year ago.
XOS Net Leverage
XOS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
BA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.1 | Neutral |
| Stochastic | 9.6 | Oversold |
BA's weekly RSI is 31 (neutral) and its Stochastic is 10 (oversold).
XOS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.3 | Neutral |
| Stochastic | 20.3 | Neutral |
XOS's weekly RSI is 45 (neutral) and its Stochastic is 20 (neutral).
BA PE vs Industrials Sector
| Metric | BA | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 24x | 26% below |
| PE % | 0 | 58 | 58 pts below |
BA is trading at 18x earnings, a 26% discount to the Industrials sector's median of 24x, though its earnings don't support one.
XOS PE vs Industrials Sector
| Metric | XOS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 24x | โ |
XOS has no meaningful PE right now: it lost money over the past year.
BA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $184.6 | 7.1% below |
| 20 week MA | $203.8 | 16% below |
| 50 week MA | $215.5 | 20% below |
| 100 week MA | $205.9 | 17% below |
| 200 week MA | $200.6 | 14% below |
BA is in a downtrend: it's below all five of its weekly moving averages, and 14% below its 200-week average.
XOS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.76 | 17% below |
| 20 week MA | $2.68 | 15% below |
| 50 week MA | $2.43 | 5.8% below |
| 100 week MA | $2.83 | 19% below |
| 200 week MA | $6.50 | 65% below |
XOS is in a downtrend: it's below all five of its weekly moving averages, and 65% below its 200-week average.
BA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $330.1 | $217.2 | -34% |
| 2021 | $217.2 | $204.2 | -6% |
| 2022 | $204.2 | $189.1 | -7.4% |
| 2023 | $189.1 | $260.7 | +38% |
| 2024 | $260.7 | $180.7 | -31% |
| 2025 | $180.7 | $216.4 | +20% |
| 2026 YTD | $216.4 | $171.6 | -21% |
BA has finished lower in four of the last six years. It's down 21% so far in 2026.
XOS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $299.7 | $302.4 | +0.9% |
| 2021 | $302.4 | $91.5 | -70% |
| 2022 | $91.5 | $16.5 | -82% |
| 2023 | $16.5 | $7.98 | -52% |
| 2024 | $7.98 | $3.16 | -60% |
| 2025 | $3.16 | $2.02 | -36% |
| 2026 YTD | $2.02 | $2.29 | +13% |
XOS has the edge over BA on returns for 2026, with the stronger performance.